<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>Icerocket blog search: tag:glaxo</title>
<link>http://blogs.icerocket.com/search?q=tag%3Aglaxo</link>
<description>Blogs Search from IceRocket.com</description>
<language>en-us</language>
<copyright>Copyright 2009, IceRocket.com</copyright>
<item>
 <title><![CDATA[Japan to reconsider import of H1N1 swine flu vaccine Pandemrix …]]></title>
 <description><![CDATA[A patient study which is currently under way in Japan to ensure the safety of Pandemrix hasn’t shown any serious side effects , stated a Glaxo spokesman in Japan. Canadian health authorities has stopped using one lot of Pandemrix vaccine … Read the original: Japan to reconsider import of H1N1 swine  <b>...</b> ]]></description>
 <link><![CDATA[http://h1n1shot.us/japan-to-reconsider-import-of-h1n1-swine-flu-vaccine-pandemrix/]]></link>
 <pubDate>Tue, 24 Nov 2009 16:19:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[830898ef68079f30e3df26fd8dced4d9]]></guid>
 <dc:creator>Jesse</dc:creator>
 <source url="http://h1n1shot.us">H1N1SHOT.US</source>
</item>
<item>
 <title><![CDATA[In Canada 36 casi di reazioni allergiche al vaccino A-H1N1. C’è pure il morto.]]></title>
 <description><![CDATA[Il vaccino contro l’influenza A è messo sotto accusa in Canada. Si tratta di Pandemrix, il prodotto della GlaxoSmithKline. In Italia non esiste, il governo ha firmato contratti con Novartis e Sanofi-Aventis. Non è previsto che sia acquistato anche Pandemrix, sebbene sia fra i prodotti autorizzati da <b>...</b> ]]></description>
 <link><![CDATA[http://yespolitical.wordpress.com/2009/11/24/in-canada-36-casi-di-reazioni-allergiche-al-vaccino-a-h1n1-ce-pure-il-morto/]]></link>
 <pubDate>Tue, 24 Nov 2009 12:40:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[5b255aaf876beca77ebe739a0a8a181d]]></guid>
 <dc:creator>cubicamente</dc:creator>
 <source url="http://yespolitical.wordpress.com">Yes, political! La rassegna stampa indignata e perplessa</source>
</item>
<item>
 <title><![CDATA[Influenza A: gravi reazioni in Canada al vaccino Gsk]]></title>
 <description><![CDATA[In Canada è stato registrato un insolito numero di gravi reazioni allergiche a un tipo di vaccino contro l’influenza A. Lo ha reso noto l’Organizzazione Mondiale della Sanità. Le autorità canadesi, ha spiegato il portavoce Thomas Abraham, «stanno compiendo le corrette ricerche» e «hanno richiamato u <b>...</b> ]]></description>
 <link><![CDATA[http://paoblog.wordpress.com/2009/11/24/influenza-a-gravi-reazioni-in-canada-al-vaccino-gsk/]]></link>
 <pubDate>Tue, 24 Nov 2009 08:06:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[0f5c1cead729c9d5a873db1b4366ad15]]></guid>
 <dc:creator>paoblog</dc:creator>
 <source url="http://paoblog.wordpress.com">Paoblog&#039;s Weblog</source>
</item>
<item>
 <title><![CDATA[GlaxoSmithKline investit dans Supergen, une société spécialisé dans la recherche de nouveaux anticancéreux : le montant pourrait atteindre 375 millions de dollars]]></title>
 <description><![CDATA[GlaxoSmithKline investit dans Supergen, une société spécialisé dans la recherche de nouveaux anticancéreux : le montant pourrait atteindre 375 millions de dollars. GlaxoSmithKline et Supergen sont rentrés dans un contrat de collaboration pour l’identification et le développement de nouveaux anticanc <b>...</b> ]]></description>
 <link><![CDATA[http://www.pharmactua.com/2009/glaxosmithkline-investit-dans-supergen-une-societe-specialise-dans-la-recherche-de-nouveaux-anticancereux-le-montant-pourrait-atteindre-375-millions-de-dollars/]]></link>
 <pubDate>Mon, 23 Nov 2009 23:51:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[fc00085fbab8ddf7373572b9fe098bb6]]></guid>
 <dc:creator>pharmactua</dc:creator>
 <source url="http://www.pharmactua.com">Pharmactua</source>
</item>
<item>
 <title><![CDATA[Glaxo Puts Hold on Some Swine Flu Shots in Canada (Update2)]]></title>
 <description><![CDATA[Glaxo Puts Hold on Some Swine Flu Shots in Canada (Update2) Post from: Swine Flu CEO Nov. 23 (Bloomberg) — Canadian doctors should hold off on using a batch of GlaxoSmithKline Plc’s swine flu vaccine while the company probes reports of higher-than-expected occurrences of a side effect known as anaph <b>...</b> ]]></description>
 <link><![CDATA[http://swinefluceo.com/?p=2565#utm_source=feed&utm_medium=feed&utm_campaign=feed]]></link>
 <pubDate>Mon, 23 Nov 2009 13:37:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[a2e16fd9fd4463aee1efb068dfd89b6f]]></guid>
 <dc:creator>MWilhelm</dc:creator>
 <source url="http://swinefluceo.com">Swine Flu CEO</source>
</item>
<item>
 <title><![CDATA[Nabi Biopharmaceuticals annonce un partenariat pour Nicvax, un vaccin expérimental contre l’addiction à la nicotine : un accord pouvant atteindre 500 millions de dollars]]></title>
 <description><![CDATA[Nabi Biopharmaceuticals et GlaxoSmithKline ont annoncé un partenariat pour la commercialisation du vaccin expérimental Nicvax pour le traitement de l’addiction à la nicotine et la prévention des rechutes. L’action de la société américaine a grimpé de 26 % au NASDAQ à la suite de la nouvelle. Nabi re <b>...</b> ]]></description>
 <link><![CDATA[http://www.pharmactua.com/2009/nabi-biopharmaceuticals-annonce-un-partenariat-pour-nicvax-un-vaccin-experimental-contre-laddiction-a-la-nicotine-un-accord-pouvant-atteindre-500-millions-de-dollars/]]></link>
 <pubDate>Fri, 20 Nov 2009 00:37:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[9a2564dccbad19b9417090a8e5dc9534]]></guid>
 <dc:creator>pharmactua</dc:creator>
 <source url="http://www.pharmactua.com">Pharmactua</source>
</item>
<item>
 <title><![CDATA[A/H1N1: CODACONS PRESENTA DIFFIDA A MINISTERO E AIFA SUL VACCINO]]></title>
 <description><![CDATA[Dopo aver ricevuto numerose segnalazioni di cittadini preoccupati per le tante notizie circolanti in queste ore relative alla sicurezza del vaccino contro l’influenza A, il Codacons ha presentato una diffida al Ministero della Salute e all’Aifa chiedendo di tirare fuori le prove dell’innocuità del p <b>...</b> ]]></description>
 <link><![CDATA[http://termoli.wordpress.com/2009/11/19/ah1n1-codacons-presenta-diffida-a-ministero-e-aifa-sul-vaccino/]]></link>
 <pubDate>Wed, 18 Nov 2009 17:03:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[c43ad2324fb196d1121894ca2b0da7b1]]></guid>
 <dc:creator>Achab</dc:creator>
 <source url="http://termoli.wordpress.com">Bacheca di vita termolese</source>
</item>
<item>
 <title><![CDATA[Vaccino A-H1N1, cronache della pandemia. Dalla Polonia attacco all’industria del farmaco.]]></title>
 <description><![CDATA[Il ministro della sanità polacco, Ewa Kopacz, si è espressa in un duro attacco ai paesi occidentali e all’industria del farmaco, sostenendo in 20 punti le ragioni del suo no all’acquisto delle milioni di dosi utili a vaccinare la popolazione polacca. Per la Kopacz, il dovere di un ministro deve esse <b>...</b> ]]></description>
 <link><![CDATA[http://yespolitical.wordpress.com/2009/11/18/vaccino-a-h1n1-cronache-della-pandemia-dalla-polonia-attacco-allindustria-del-farmaco/]]></link>
 <pubDate>Wed, 18 Nov 2009 14:47:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[27a4d78a195d4ca668566fe4823d15d1]]></guid>
 <dc:creator>cubicamente</dc:creator>
 <source url="http://yespolitical.wordpress.com">Yes, political! La rassegna stampa indignata e perplessa</source>
</item>
<item>
 <title><![CDATA[ViiV Healthcare : Une alliance de 2,7 milliards entre GlaxoSmithKline et Pfizer pour concurrencer Gilead, le groupe pharmaceutique américain, leader des traitements contre le sida avec 5 milliards de  ...]]></title>
 <description><![CDATA[Le groupe GlaxoSmithKline, cinquième mondial et Pfizer, premier mondial de la pharmacie ont créé ViiV Healthcare, détenu à 85 % par GlaxoSmithKline et 15 % par Pfizer, un groupe pharmaceutique mutualisant le portefeuille de médicament contre le sida des deux groupes d’une valeur de 2,3 milliards de  <b>...</b> ]]></description>
 <link><![CDATA[http://www.pharmactua.com/2009/viiv-healthcare-une-alliance-de-27-milliards-entre-glaxosmithkline-et-pfizer-pour-concurrencer-gilead-le-groupe-pharmaceutique-americain-leader-des-traitements-contre-le-sida-avec-5-milliards-de/]]></link>
 <pubDate>Tue, 17 Nov 2009 01:11:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[d3c6fc89c8e2fb53a361f2fd1ba17e88]]></guid>
 <dc:creator>pharmactua</dc:creator>
 <source url="http://www.pharmactua.com">Pharmactua</source>
</item>
<item>
 <title><![CDATA[FDA Approves Additional Vaccine For 2009 H1N1 Influenza Virus (BioresearchOnline)]]></title>
 <description><![CDATA[The U.S. Food and Drug Administration announced that it has approved a fifth vaccine for protection against the 2009 H1N1 influenza virus. The vaccine is manufactured by ID Biomedical Corp. of Quebec, Canada, owned by GlaxoSmithKline PLC. See the rest here: FDA Approves Additional Vaccine For 2009 H <b>...</b> ]]></description>
 <link><![CDATA[http://h1n1influenzavirus.us/fda-approves-additional-vaccine-for-2009-h1n1-influenza-virus-bioresearchonline/]]></link>
 <pubDate>Tue, 17 Nov 2009 01:06:00 CST</pubDate>
 <guid isPermaLink="false"><![CDATA[b1ee78fe1f10fd3376fed3666b826173]]></guid>
 <dc:creator>Jesse</dc:creator>
 <source url="http://h1n1influenzavirus.us">H1N1INFLUENZAVIRUS.US</source>
</item>
</channel>
</rss>


